CD276 is an immune checkpoint molecule in the epithelial-mesenchymal transformation (EMT) pathway, which plays a crucial part in the cell proliferation, invasion, and migration of malignant tumors, and is a promising therapeutic target for tumors [33]. The gene discussed is CD276; the disease is cancer.